AI At The Frontier: Empowering Early Career Professionals In Drug Discovery
Elrig
APRIL 29, 2024
Fascinated by the potential of AI in medical research, I transitioned to BenevolentAI in early 2023 as a Biology Project Leader. There, I supported AI-enabled DD efforts in their small molecule portfolio. Driven by an interest in drug discovery Millie joined AstraZeneca after completion of her PhD at the end of 2020.
59 
Let's personalize your content